Long-term Safety and Efficacy of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years with Mild to Moderate Atopic Dermatitis: a 52-Week, Phase 3, Open-Label Extension Trial
BRITISH JOURNAL OF DERMATOLOGY（2024）
Key words
atopic dermatitis,long-term,roflumilast cream,safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined